We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Mutation Causes Death of Motor Neurons in ALS

By Biotechdaily staff writers
Posted on 17 Mar 2008
Researchers in the field of neurodegenerative disorders have identified a gene linked to both the familial and sporadic forms of amyotrophic lateral sclerosis (ALS).

ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. More...
The progressive degeneration of motor neurons in ALS eventually leads to their death. Lack of motor neurons causes the brain to lose the ability to initiate and control muscle movement, leading to progressive paralysis. On the molecular level, the disorder is characterized by ubiquitinated TAR DNA binding protein (TDP-43) inclusions. TDP-43 had been previously identified as a major component of the protein inclusions found in ALS patients' motor neurons.

Investigators at King's College (London, UK) compared gene maps of ALS patients with those of a large number of normal individuals. They reported in the February 28, 2008, online edition of the journal Science that there were single base mutations in the TDP-43 gene in five affected members of one family, compared to none in unaffected members. They also found mutations in two ALS patients with no family history of the disease (sporadic ALS). No mutations were found in 1,262 unaffected controls or in 523 other ALS cases. In all, three mutations were found, all affecting one region of the protein. In the familial case, the mutation was inherited in an autosomal dominant fashion (one mutant copy was sufficient to cause the disease).

In a second report published in the February 20, 2008, online edition of the Annals of Neurology the investigators presented additional evidence of a direct link between altered TDP-43 function and neurodegeneration.

"The identification of TDP-43 gene mutations in ALS places TDP-43 protein at center stage as a potential cause of motor neuron degeneration. Critically, these mutations will give scientists around the world a new tool to explore the disease process and hopefully accelerate drug discovery,” said senior author Dr. Christopher Shaw, professor of clinical neuroscience at King's College.


Related Links:
King's College

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.